Liang, Feng
Yang, Qiwu
Xie, Lanfeng
Ma, Jun
Zhao, Wenkai
Xiao, Zhiyong
Wang, Zhen
Li, Caoyuan
Liu, Yilin
Chang, Wei
Zhou, Suzhen
Wu, Zhaoxia
Yan, Donghong
Funding for this research was provided by:
Shanghai Sixth People’s Hospital Group (Ly202201)
Xinxiang Key laboratory for Precision Therapeutics of Small Cell Lung Cancer (ZDSYS-213)
Article History
Received: 31 October 2025
Accepted: 26 March 2026
First Online: 6 April 2026
Declarations
:
: The authors declare no competing interests.
: The animal study protocol was approved by the ethical committee of Shanghai Tongren Hospital.